AMERIPRISE FINANCIAL INC - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 74 filers reported holding SILVERBACK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$584,051
-68.4%
154,511
-44.1%
0.00%
-100.0%
Q2 2023$1,850,447
+1.4%
276,186
-1.5%
0.00%0.0%
Q1 2023$1,824,942
+504.3%
280,329
+691.7%
0.00%
Q4 2022$302,000
+53.3%
35,410
-5.1%
0.00%
Q3 2022$197,000
-98.6%
37,295
-91.7%
0.00%
-100.0%
Q2 2021$13,848,000
-25.4%
448,294
+5.4%
0.00%
-33.3%
Q1 2021$18,564,000
-6.4%
425,497
-0.8%
0.01%
-14.3%
Q4 2020$19,841,000428,7140.01%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$10,085,0003.26%
K2 PRINCIPAL FUND, L.P. 3,247,533$16,890,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,045,234$5,519,0001.09%
Orbimed Advisors 8,740,887$46,152,0000.86%
Rubric Capital Management LP 2,695,170$14,230,0000.72%
Prosight Management, LP 196,257$1,036,0000.56%
Nantahala Capital Management 1,249,863$6,599,0000.43%
Oasis Management Co Ltd. 317,662$1,677,0000.28%
TANG CAPITAL MANAGEMENT LLC 409,463$2,162,0000.26%
APOGEM CAPITAL LLC 13,793$73,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders